An unusual six-co-ordinate platinum(II) complex containing a neutral I2 ligand

The present paper deals with a rare platinum(II) complex containing the kappa-I2 ligand, which is an unusual example of a six-co-ordinated octahedral platinum(II) complex.     

Hydrogen bonding directs the H2O2 oxidation of platinum(II) to a cis-dihydroxo platinum(IV) complex

The use of ligands with proximate hydrogen bonding substituents in the oxidation of platinum(II) dimethyl complexes with H2O2 leads to the exclusive formation of an unusual cis-dihydroxo platinum(IV) complex, which can dehydrate to form a trinuclear metalla-azacrown complex.     

Novel luminescent hexanuclear platinum(II) alkynyl complex: molecular lego from a face-to-face dinuclear platinum(II) building block

A novel luminescent hexanuclear platinum(II) complex, [Pt(2)(mu-dppm)(2)(C[triple bond]CC(5)H(4)N)(4)[Pt(trpy)](4)](CF(3)SO(3))(8) (trpy = 2,2':6',2'-terpyridine), was successfully synthesized by using the face-to-face dinuclear platinum(II) ethynylpyridine complex [Pt(2)(mu-dppm)(2)(C[triple bond]CC(5)H(4)N)(4)] as the building block.     

Synthesis and characterization of a platinum(II) complex with N-acetyl-L-cysteine

Synthesis and spectroscopic studies in the solid-state of a platinum(II) complex with N-acetyl-L-cysteine are described. Elemental analyses are consistent with composition Pt₂(C₅H₈NO₃S)₄ · 3H₂O. Solid-state ¹³C NMR, infrared, and U-Vis spectroscopic results are consistent with coordination of the ligand to platinum(II) through sulfur. Thermal analyses confirmed water in the complex composition. Final residue of the thermal treatment was identified by powder X-ray diffractometry as metallic platinum.     

Five-coordinate platinum(IV) complex as a precursor to a novel Pt(II) olefin hydride complex for alkane activation

The five-coordinate platinum(IV) complex (nacnac)PtMe3 (nacnac- = [{(o-iPr2C6H3)NC(CH3)}2CH]-) thermally eliminates ethane and methane to produce a novel olefin(hydrido)platinum(II) complex, where the olefin is part of the nacnac-type ligand. This Pt(II) product activates hydrocarbons, including alkanes under mild conditions, as indicated by scrambling of hydrogen and deuterium between the hydrocarbon solvent and selected positions on the ligand of the platinum complex. A mechanism in which olefin insertion into the metal hydride bond opens a site to allow hydrocarbon coordination and C-H bond oxidative addition is proposed.     

Organoplatinum(II) complexes containing chelating or bridging bis(N-heterocyclic carbene) ligands: formation of a platinum(II) carbonate complex by aerial CO2 fixation

The preparation of two new bis(N-heterocyclic carbene) platinum(II) complexes, in which NHC rings are joined by a CH(2) linker group, is described. While, the chelate complex [PtMe(2)(bis-NHC1)], 1, was formed with large tert-butyl wingtips, the iso-propyl N-substituent analogue favors formation of the cluster complex [Pt(2)Me(4)(μ-SMe(2))(μ-bis-NHC2)](2)(μ-Ag(2)Br(2)), 2, in which two binuclear platinum(II) complexes are linked together by an Ag(2)Br(2) unit. The chelating platinum complex 1 undergoes aerial CO(2) fixation and forms platinum(II) carbonate complex [Pt(CO(3))(bis-NHC1)], 3.     

Structural features of a new dinuclear platinum(II) complex with significant antiproliferative activity

A novel dinuclear platinum(II) complex, [Pt(2)-N,N'-bis(2-dimethylaminoethyl oxamide)Cl(4)], showing peculiar structural features, has been prepared and characterized. X-ray diffraction data reveal that the two platinum ions are simultaneously bound to the N,N'-bis(2-dimethylaminoethyl) oxamide ligand, on opposite sides. The coordination environment of both platinum centers is square planar, with identical NOCl(2) donor sets. The complex is poorly soluble within a physiological buffer but moderately soluble in DMSO. Preliminary in vitro studies point out that this dinuclear platinum complex exhibits significant growth-inhibiting properties on a panel of cultured human tumor cell lines, although less pronounced than those of cisplatin.     

Photo-controllable tristability of a dithiolato-bipyridine-Pt(II) complex molecule containing two azobenzene moieties

A new platinum complex with both an azo-bound dithiolato ligand and an azobenzene-bound bipyridine ligand exhibits tristability reversibly controllable using different energy lights.     

Sulfur- and oxygen-containing platinum(II) complex

Russian Journal of General Chemistry - Mixed-ligand platinum(II) complex with ethylenedithiodiacetic acid (HSSH) and thioglycolic acid has been synthesized. Ethyleneditiodiacetate is coordinated to...     

Synthesis and optoelectronic properties of a carbazole-modified platinum(II) complex in polymer light-emitting devices

To improve opto-electronic properties and efficiently suppress excimer emission, a phenylpyridine (ppy)-based platinum(II) complex (C(16)OCz-ppy)Pt(acac) was synthesized and characterized, where C(16)OCz-ppy is a 2-phenylpyridine derivative appending a carbazole moiety and three hexadecyloxy methyl units in the parent phenylpyridine, and acac is acetylacetone. This carbazole-modified platinum(II) complex exhibited good thermal stability and three times higher photoluminescent quantum yield than its parent (2-phenylpyridine-C(2),N)(2,4-pentanedionato-O,O)platinum(II) complex [(ppy)Pt(acac)]. Single-emissive-layer polymer light-emitting devices using (C(16)OC(Z)-ppy)Pt(acac) as dopant and a blend of poly(N-vinylcarbazole) and 2-(4-biphenyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole as host matrix presented a maximum current efficiency of 1.51 cd A(-1), which was 1.5 times higher than that from the (ppy)Pt(acac)-doped device with the same device structure. Little excimer emission and minor aggregation emission were observed in the (C(16)OC(Z)-ppy)Pt(acac)-doped PLEDs at different dopant concentrations and applied voltages. This work indicates that introducing a carbazole and three hexadecyloxy methyl groups into the planar platinum(II) complex can reduce molecular aggregation and excimer emissions, thus resulting in high luminance and stable EL spectra in comparison with the parent (ppy)Pt(acac).     

Synthesis of a platinum(II) complex of chloroanilic acid

Conclusions A platinum(II) complex of chloroanilic acid was synthesized. This complex is isostructural to the analogous palladium complex and has the formula [Pt(C₆O₄Cl₂)Cl₂]K₂'H₂O.Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 9, pp. 2123–2124, September, 1986.The authors thank O. N. Krasochka for a preliminary x-ray diffraction analysis of this complex.     

Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).

The reaction of dihydroxo(1R,2R-cyclohexanediamine)platinum(II) with (-)-quinic acid gave a water soluble complex, (-)-quinato(1R,2R-cyclohexanediamine)platinum(II). The crystal structure of the complex was determined by X-ray analysis. The data indicate a chelation of the alpha-hydroxycarboxylic acid part of quinic acid to platinum(II). The complex shows moderate antitumor activity against murine leukemia L1210 at high doses (T/C x 100 = 179% at a dose of 200 mg/kg).     

Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor

Bisphosphonates have high affinity for hydroxyapatite (HA), which is abundantly present in bone. Also, platinum complexes are known that have a wide spectrum of antitumor activities. The conjugate of bisphosphonate and a platinum complex might have HA affinity and antitumor activity, and become a drug for metastatic bone tumor. In this study, the authors synthesized platinum complexes that had dialkyl bisphosphonic acid as a ligand, and evaluated the possibility of the synthesized complexes as a drug for metastatic bone tumor. The synthesized dialkyl bisphosphonate platinum(II) complex was characterized, and its stability in an aqueous solution was also confirmed. The synthesized platinum complex showed higher HA affinity than other platinum complexes such as cisplatin and carboplatin in an experiment of adsorption to HA. In vitro, the platinum complex showed tumor growth inhibitory effect stronger than or equal to cisplatin, which is the most commonly used antitumor agent. Moreover, the platinum complex showed a bone absorption inhibitory effect on the osteoclast. These results suggest potential of dialkyl bisphosphonate platinum(II) complexes as a drug for metastatic bone tumor.     

Disulfide bond cleavage induced by a platinum(II) methionine complex

The cleavage of a disulfide bond and the redox equilibrium of thiol/disulfide are strongly related to the levels of glutathione (GSH)/oxidized glutathione (GSSG) or mixed disulfides in vivo. In this work, the cleavage of a disulfide bond in GSSG induced by a platinum(II) complex [Pt(Met)Cl2] (where Met = methionine) was studied and the cleavage fragments or their platinated adducts were identified by means of electrospray mass spectrometry, high-performance liquid chromatography, and ultraviolet techniques. The second-order rate constant for the reaction between [Pt(Met)Cl2] and GSSG was determined to be 0.4 M(-1) s(-1) at 310 K and pH 7.4, which is 100- and 12-fold faster than those of cisplatin and its monoaqua species, respectively. Different complexes were formed in the reaction of [Pt(Met)Cl2] with GSSG, mainly mono- and dinuclear platinum complexes with the cleavage fragments of GSSG. This study demonstrated that [Pt(Met)Cl2] can promote the cleavage of disulfide bonds. The mechanistic insight obtained from this study may provide a deeper understanding on the potential involvement of platinum complexes in the intracellular GSH/GSSG systems.     

White emission from dinuclear cyclometalated platinum(II) complex in single-emitting layer PLEDs

A dinuclear platinum(II) complex of (dfppy)₂Pt₂(dipic) has been prepared, where dfppy is 2,4-difluorophenylpyridine and dipic is a biphenyl-bridged bi-picolinic acid derivative. Its physical and optoelectronic properties, as well as molecular orbitals calculation have been investigated and compared with those of its mono-nuclear (dfppy)Pt(pic) complex. Both platinum(II) complexes exhibited almost identical photoluminescence (PL) spectra with deep blue emission in dilute dichloro-methane (10⁻⁵ M) and different PL spectra with red emission in their neat films. Stable white emissions were obtained in the (dfppy)₂Pt₂(dipic)-doped polymer light-emitting devices using a blend of poly(vinylcarbazole) and 2-(4-biphenyl)-5-(4-tert-butyl-phenyl)-1,3,4-oxadiazole as a host matrix at dopant concentrations from 1 wt % to 10 wt %. In contrast, the (dfppy)Pt(pic)-doped devices exhibited orange-red emissions in the same device configuration. It indicates that dinuclear platinum(II) complex with a non-planar structure is an effective way to control formation excimers of platinum(II) complex and get white-emitting PLEDs with single dopant.     

IRA-200 resin-supported platinum(II) complex for photooxidation of olefins

Cyclometalated platinum(II) 4,6-diphenyl-2,2′-bipyridine complex is supported on a commercially available cationic ion-exchange resin (amberlite IRA-200). Photophysical and ESR determinations indicate that the combined photosensitized system is able to generate singlet oxygen with high quantum yield upon irradiation of light in the visible region. The platinum(II) complex loaded on IRA-200 resin is stable and the photooxidation occurs in an environmentally friendly way. Only a simple filtration is needed to recycle the expensive metal catalyst.     

Diastereoselective assembling of 21-C-alkylated nickel(II) complexes of inverted porphyrin on a platinum(II) template

Reaction of 21-C-methyl and 21-C-benzyl nickel(II) complexes of inverted meso-tetratolylporphyrin with platinum(II) dichloride or its bis(benzonitrile) complex yields a chloroplatinum(II) species containing two nickel(II) carbaporphyrinoids in a cis arrangement. One of the carbaporphyrinoids coordinates to the platinum ion with the external nitrogen while the other is bound with the external nitrogen and one ortho-carbon of the adjacent meso-aryl ring. The reaction is highly chemoselective. (1)H and (13)C NMR experiments in solution show the diastereoselectivity of the reaction. Single-crystal X-ray data confirm the presence of the diastereomer with opposite configurations of the Ni(II)-coordinated carbons in the subunits of the dimer. Cyclovoltammetric measurements reveal an anodic shift of the nickel(II) oxidation potentials of dimers with respect to those of the parent monomers and two different reduction couples. Reaction of unsubstituted inverted porphyrin with Pt(PhCN)(2)Cl(2) in chlorobenzene yields a monomeric platinum(II) complex of inverted porphyrin. This complex displays a markedly upfield (195)Pt NMR shift compared to tetraphenylporphyrinatoplatinum(II). Under strongly basic conditions deprotonation of the external nitrogen of inverted porphyrin and both electrochemical and chemical oxidation of platinum(II) center are observed.     

双马来腈二亚胺合铂与DNA的作用

本文以紫外-可见光谱、荧光光谱及黏度法研究了双马来腈二亚胺合铂与DNA的作用。紫外-可见光谱的研究表明,与DNA作用后,双马来腈二亚胺合铂在可见区的吸收显示出了减色效应,并伴随着吸收峰的蓝移。Scatchard图的分析结果表明,双马来腈二亚胺合铂与DNA的作用位点与溴化乙锭不同。黏度法实验表明,双马来腈二亚胺合铂与DNA作用后降低了DNA的相对黏度。这些研究结果表明,双马来腈二亚胺合铂以静电作用方式与DNA结合。本研究有助于深入理解双马来腈二亚胺合铂的作用机理并开发这种潜在的新型光动力治疗剂。     

Synthesis,characterization and initial biological studies of a new platinum(II) complex with deoxyalliin

A new platinum(II) complex with deoxyalliin was synthesized and characterized by chemical and spectroscopic techniques. Elemental and mass spectrometry analyses of the solid complex fit to the composition [Pt(C₆H₁₁NO₂S)Cl₂]·H₂O. ¹³C NMR, ¹⁵N NMR and infrared spectra of the complex are consistent with coordination of deoxyalliin to Pt(II) through the nitrogen and sulfur atoms forming a square-planar geometry. The complex is soluble in dimethylsulfoxide. Biological analysis for evaluation of a potential cytotoxic effect of the complex was performed using HeLa cells, a human cervix adenocarcinoma-derived cell line. The results were compared with those of a palladium(II) complex previously described.     

Excited-state equilibration over 30 A in a platinum(II) quinolinolate-bridge-platinum(II) porphyrin complex

Long-range triplet excited-state equilibration occurs over a nanometric distance between platinum(II) 8-quinolinolate (3Ptq2 = 1.87 eV) and platinum(II) tetraphenylporphyrin (3PtTPP = 1.89 eV). The equilibrium is mediated by a fluorene-thiophene-fluorene bridge (3FTF = 1.92 eV) and is characterized by a double-exponential decay (tau1 = 39 +/- 4 ps; tau2 = 351 +/- 15 ps) that suggests the participation of three separate excited states: 3Ptq2, 3FTF, and 3PtTPP, respectively. Numerical simulation of the dual equilibrium allowed for estimation of the individual rate constants for each of the reversible steps (kET = 3.9 x 10(9)-4.1 x 10(10) s(-1)). As a result of rapid triplet-state equilibration, almost 50% of the excited-state energy is directed from the PtTPP chromophore toward Ptq2, in spite of a small endothermic barrier (0.03 eV).